• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍奇金病的骨髓受累——7例临床病理研究

Bone marrow involvement in Hodgkin's disease -- clinicopathological study of seven cases.

作者信息

Chopra R, Kumar S, Rana R, Zachariah A

机构信息

Departments of Pathology and Medicine, Christian Medical College, Ludhiana.

出版信息

Indian J Pathol Microbiol. 1995 Jul;38(3):267-71.

PMID:8819658
Abstract

Bone marrow involvement was observed in 7 cases amongst a total of 75 cases of Hodgkin's disease encountered between January 1981 and June 1990; thus representing an incidence of 9.3 percent. Analysis of these 7 cases showed male preponderance. The age ranged from 26 to 74 years. All patients presented within seven months of onset of symptoms; and all had symptoms at presentation. Lymphadenopathy was found in all the cases, splenomegaly was present in six; and hepatomegaly in 4 cases. Mixed cellularity and lymphocytic depletion subtypes showed the highest frequency of marrow involvement (6 cases; 85.7 percent). Alkaline phosphatase was raised in 6 cases (85.7%). All cases received standard combination chemotherapy with or without local radiation therapy. Two years follow-up revealed an overall survival of 42.9%. Replace free survival at the end of two years was zero, as all the cases relapsed within seven months of initiation of treatment.

摘要

在1981年1月至1990年6月期间收治的75例霍奇金病患者中,有7例观察到骨髓受累,发病率为9.3%。对这7例患者的分析显示男性居多。年龄范围为26至74岁。所有患者在症状出现后7个月内就诊,且就诊时均有症状。所有病例均发现有淋巴结病,6例有脾肿大,4例有肝肿大。混合细胞型和淋巴细胞消减型骨髓受累频率最高(6例,85.7%)。6例(85.7%)碱性磷酸酶升高。所有病例均接受了标准联合化疗,部分接受或未接受局部放射治疗。两年随访显示总生存率为42.9%。两年末的无复发生存率为零,因为所有病例在开始治疗后7个月内均复发。

相似文献

1
Bone marrow involvement in Hodgkin's disease -- clinicopathological study of seven cases.霍奇金病的骨髓受累——7例临床病理研究
Indian J Pathol Microbiol. 1995 Jul;38(3):267-71.
2
Hodgkin's disease with bone marrow involvement.伴有骨髓受累的霍奇金淋巴瘤。
Indian J Cancer. 1989 Jun;26(2):58-66.
3
[Clinico-pathological characteristics, response to therapy and survival of patients with bone marrow infiltration by Hodgkin's lymphoma].[霍奇金淋巴瘤骨髓浸润患者的临床病理特征、治疗反应及生存情况]
Srp Arh Celok Lek. 1995 Mar-Apr;123(3-4):68-72.
4
[Clinicopathological studies on bone marrow involvement of non-Hodgkin's lymphoma].[非霍奇金淋巴瘤骨髓受累的临床病理研究]
Zhonghua Zhong Liu Za Zhi. 2000 Nov;22(6):513-5.
5
Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.异基因骨髓移植治疗复发难治性霍奇金淋巴瘤和非霍奇金淋巴瘤。
Bone Marrow Transplant. 1997 Sep;20(5):369-74. doi: 10.1038/sj.bmt.1700904.
6
Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral centre.霍奇金淋巴瘤:一家大型转诊中心15年经验的回顾性分析。
Natl Med J India. 1998 Sep-Oct;11(5):212-7.
7
Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.米托蒽醌、长春碱和洛莫司汀(环己亚硝脲)(MVC):一种用于晚期及预后不良霍奇金淋巴瘤的高效治疗方案。
Cancer J Sci Am. 1998 Jul-Aug;4(4):254-60.
8
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].[高剂量化疗及自体干细胞移植作为难治性和复发性霍奇金淋巴瘤的一线治疗——舍巴医疗中心(特拉维夫索罗卡大学医学中心)的研究]
Harefuah. 2000 Sep;139(5-6):174-9, 248, 247.
9
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).首次复发或第二次缓解期霍奇金病的自体移植:来自自体血液和骨髓移植登记处(ABMTR)的报告
Bone Marrow Transplant. 2001 Feb;27(4):387-96. doi: 10.1038/sj.bmt.1702796.
10
[Risk factors for bone marrow involvement in Hodgkin's disease].
Vopr Onkol. 2001;47(1):39-44.